Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis

Objective: To describe postprandial lipemia in patients with rheumatoid arthritis (RA) and to analyze its association with subclinical atherosclerosis measured as carotid intima-media thickness (cIMT). Methods: We performed an observational study of 40 patients with RA and 40 sex and age-matched con...

Full description

Bibliographic Details
Main Authors: Natalia Mena-Vázquez, Marta Rojas-Gimenez, Francisco Gabriel Jimenez Nuñez, Sara Manrique-Arija, José Rioja, Patricia Ruiz-Limón, Inmaculada Ureña, Manuel Castro-Cabezas, Pedro Valdivielso, Antonio Fernández-Nebro
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/8/2483
_version_ 1797560464374235136
author Natalia Mena-Vázquez
Marta Rojas-Gimenez
Francisco Gabriel Jimenez Nuñez
Sara Manrique-Arija
José Rioja
Patricia Ruiz-Limón
Inmaculada Ureña
Manuel Castro-Cabezas
Pedro Valdivielso
Antonio Fernández-Nebro
author_facet Natalia Mena-Vázquez
Marta Rojas-Gimenez
Francisco Gabriel Jimenez Nuñez
Sara Manrique-Arija
José Rioja
Patricia Ruiz-Limón
Inmaculada Ureña
Manuel Castro-Cabezas
Pedro Valdivielso
Antonio Fernández-Nebro
author_sort Natalia Mena-Vázquez
collection DOAJ
description Objective: To describe postprandial lipemia in patients with rheumatoid arthritis (RA) and to analyze its association with subclinical atherosclerosis measured as carotid intima-media thickness (cIMT). Methods: We performed an observational study of 40 patients with RA and 40 sex and age-matched controls. Patients with dyslipidemia were excluded. Pathologically increased cIMT was defined as a carotid thickness greater than the 90th percentile (>p90) for age and sex. Fasting and postprandial plasma lipids, cholesterol, triglycerides, apolipoprotein B48 (ApoB48), and total ApoB were evaluated. The other variables included were clinical and laboratory values, Framingham score, and the 28-joint Disease Activity Score (DAS28). Two multivariate models were constructed to identify factors associated with pathologic cIMT in patients with RA. Results: Fasting lipid values were similar in patients with RA and controls, although those of postprandial ApoB48 were higher (median (IQR), 14.4 (10.8–12.1) vs. 12.1 (2.3–9,8); <i>p</i> = 0.042). Pathologic cIMT was recorded in 10 patients with RA (25%) and nine controls (22.5%). In patients with RA, pathologic cIMT was associated with postprandial ApoB48 (OR (95% CI), 1.15 (1.0–1.3)) and total ApoB (OR [95% CI], 1.12 [1.1–1.2]). The second model revealed a mean increase of 0.256 mm for cIMT in patients with elevated anticitrullinated protein antibodies (ACPAs). Conclusion: Postprandial ApoB48 levels in patients with RA are higher than in controls. Postprandial ApoB48 and total ApoB levels and markers of severity, such as ACPAs, are associated with pathologic cIMT in patients with RA. Our findings could indicate that these atherogenic particles have a negative effect on the endothelium.
first_indexed 2024-03-10T18:00:55Z
format Article
id doaj.art-4df4524ce7774b43a08305ead62d158b
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T18:00:55Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-4df4524ce7774b43a08305ead62d158b2023-11-20T08:51:46ZengMDPI AGJournal of Clinical Medicine2077-03832020-08-0198248310.3390/jcm9082483Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid ArthritisNatalia Mena-Vázquez0Marta Rojas-Gimenez1Francisco Gabriel Jimenez Nuñez2Sara Manrique-Arija3José Rioja4Patricia Ruiz-Limón5Inmaculada Ureña6Manuel Castro-Cabezas7Pedro Valdivielso8Antonio Fernández-Nebro9The Institute of Biomedical Research in Malaga (IBIMA), 29010 Málaga, SpainUGC de Reumatología, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofia, 14004 Córdoba, SpainThe Institute of Biomedical Research in Malaga (IBIMA), 29010 Málaga, SpainThe Institute of Biomedical Research in Malaga (IBIMA), 29010 Málaga, SpainThe Institute of Biomedical Research in Malaga (IBIMA), 29010 Málaga, SpainThe Institute of Biomedical Research in Malaga (IBIMA), 29010 Málaga, SpainThe Institute of Biomedical Research in Malaga (IBIMA), 29010 Málaga, SpainDepartment of Internal Medicine, Franciscus Gasthuis & Vlietland, Kleiweg 500, 3045 PM Rotterdam, The NetherlandsThe Institute of Biomedical Research in Malaga (IBIMA), 29010 Málaga, SpainThe Institute of Biomedical Research in Malaga (IBIMA), 29010 Málaga, SpainObjective: To describe postprandial lipemia in patients with rheumatoid arthritis (RA) and to analyze its association with subclinical atherosclerosis measured as carotid intima-media thickness (cIMT). Methods: We performed an observational study of 40 patients with RA and 40 sex and age-matched controls. Patients with dyslipidemia were excluded. Pathologically increased cIMT was defined as a carotid thickness greater than the 90th percentile (>p90) for age and sex. Fasting and postprandial plasma lipids, cholesterol, triglycerides, apolipoprotein B48 (ApoB48), and total ApoB were evaluated. The other variables included were clinical and laboratory values, Framingham score, and the 28-joint Disease Activity Score (DAS28). Two multivariate models were constructed to identify factors associated with pathologic cIMT in patients with RA. Results: Fasting lipid values were similar in patients with RA and controls, although those of postprandial ApoB48 were higher (median (IQR), 14.4 (10.8–12.1) vs. 12.1 (2.3–9,8); <i>p</i> = 0.042). Pathologic cIMT was recorded in 10 patients with RA (25%) and nine controls (22.5%). In patients with RA, pathologic cIMT was associated with postprandial ApoB48 (OR (95% CI), 1.15 (1.0–1.3)) and total ApoB (OR [95% CI], 1.12 [1.1–1.2]). The second model revealed a mean increase of 0.256 mm for cIMT in patients with elevated anticitrullinated protein antibodies (ACPAs). Conclusion: Postprandial ApoB48 levels in patients with RA are higher than in controls. Postprandial ApoB48 and total ApoB levels and markers of severity, such as ACPAs, are associated with pathologic cIMT in patients with RA. Our findings could indicate that these atherogenic particles have a negative effect on the endothelium.https://www.mdpi.com/2077-0383/9/8/2483rheumatoid arthritispostprandial lipemiaapolipoprotein B48subclinical atherosclerosis
spellingShingle Natalia Mena-Vázquez
Marta Rojas-Gimenez
Francisco Gabriel Jimenez Nuñez
Sara Manrique-Arija
José Rioja
Patricia Ruiz-Limón
Inmaculada Ureña
Manuel Castro-Cabezas
Pedro Valdivielso
Antonio Fernández-Nebro
Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
Journal of Clinical Medicine
rheumatoid arthritis
postprandial lipemia
apolipoprotein B48
subclinical atherosclerosis
title Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
title_full Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
title_fullStr Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
title_full_unstemmed Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
title_short Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis
title_sort postprandial apolipoprotein b48 is associated with subclinical atherosclerosis in patients with rheumatoid arthritis
topic rheumatoid arthritis
postprandial lipemia
apolipoprotein B48
subclinical atherosclerosis
url https://www.mdpi.com/2077-0383/9/8/2483
work_keys_str_mv AT nataliamenavazquez postprandialapolipoproteinb48isassociatedwithsubclinicalatherosclerosisinpatientswithrheumatoidarthritis
AT martarojasgimenez postprandialapolipoproteinb48isassociatedwithsubclinicalatherosclerosisinpatientswithrheumatoidarthritis
AT franciscogabrieljimeneznunez postprandialapolipoproteinb48isassociatedwithsubclinicalatherosclerosisinpatientswithrheumatoidarthritis
AT saramanriquearija postprandialapolipoproteinb48isassociatedwithsubclinicalatherosclerosisinpatientswithrheumatoidarthritis
AT joserioja postprandialapolipoproteinb48isassociatedwithsubclinicalatherosclerosisinpatientswithrheumatoidarthritis
AT patriciaruizlimon postprandialapolipoproteinb48isassociatedwithsubclinicalatherosclerosisinpatientswithrheumatoidarthritis
AT inmaculadaurena postprandialapolipoproteinb48isassociatedwithsubclinicalatherosclerosisinpatientswithrheumatoidarthritis
AT manuelcastrocabezas postprandialapolipoproteinb48isassociatedwithsubclinicalatherosclerosisinpatientswithrheumatoidarthritis
AT pedrovaldivielso postprandialapolipoproteinb48isassociatedwithsubclinicalatherosclerosisinpatientswithrheumatoidarthritis
AT antoniofernandeznebro postprandialapolipoproteinb48isassociatedwithsubclinicalatherosclerosisinpatientswithrheumatoidarthritis